OLIG 2 inhibitors (Curtana)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOLIG 2 inhibitors (Curtana)
Drug Alias NameOLIG 2 inhibitors (Curtana)CT-102 (Curtana)oligodendrocyte transcription factor 2 inhibitors (Curtana)oligodendrocyte transcription factor 2 inhibitors (Curtana)SKOG-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOligodendrocyte transcription factor 2 inhibitors
TargetsOligodendrocyte transcription factor 2
Therapy Area/IndicationsBrain NeoplasmsGlioblastomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San Diego
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California San DiegoCurtana Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsBrain NeoplasmsGlioblastomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A